|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
Valves in the Heart of the Big Apple: Evaluation & Management of Valvular Heart Diseases 2002 | ||||||||||||||||
September 21, 2001 | ||||||||||||||||
Weill Medical College of Cornell University, New York City May 2- 3, 2002 Wednesday, May 1, 2002 Registration Thursday, May 2, 2002 Registration and Continental Breakfast Daniel J. Williford, M.D., Ph.D. President, American College of Cardiology, New York State Chapter and Immediate Past President, New York Cardiological Society of the American College of Cardiology, New York State Chapter Introduction and Symposium Goals Jeffrey S. Borer, MD; O. Wayne Isom, M.D. OVERVIEW Chairman: O. Wayne Isom, M.D. THE HOWARD GILMAN FOUNDATION LECTURE Where have we come from and where are we going? Valve disease management past, present and future Joseph K. Perloff, M.D. The epidemiology of valvular heart diseases: the problem is growing Phyllis Supino, Ed.D. Echocardiographic techniques for estimation of valvular dysfunction: measurement and importance of regurgitant volume and diastolic performance, detection of mitral valve prolapse Jamil Tajik, M.D. Post-cardiotomy support strategies after valve surgery Mehmet Oz, M.D. Prevention of perioperative stroke: perspectives on intra-operative pump pressures and post-operative anticoagulation Karl Krieger, M.D. Panel Discussion/Q & A Karl Krieger, Chairman; Drs. Supino, Tajik, Oz, Perloff, Isom, Borer Coffee Break CONGENITAL LESIONS WITH VALVULAR COMPONENTS Chairman: John Lamberti, M.D. Tetralogy of Fallot: current management and effect of pulmonic insufficiency on natural course after repair John Lamberti, M.D. Mitral and tricuspid regurgitation associated with shunt lesions: endocardial cushion defects Embryology, range of pathology and functional deficits Rubin Cooper, M.D. Techniques and long-term results of surgical intervention Jan Quagebeur, M.D. Pulmonic stenosis: natural history, indications for valvotomy, choice of procedure William Z. Hillenbrand, M.D. Panel Discussion/Q & A Joseph K. Perloff, M.D., Chairman; Drs. Lamberti, Cooper, Quagebeur, Gold Lunch Unrecognized valvular disease and sudden death in the athlete Arthur (“Archie”) Roberts, M.D. President, The Living Heart Foundation and Director, National Cardiac Screening Lifestyle Initiative (Former Chief, Cardiac Surgery, Northwestern University, University of Florida, Boston University, and last football All-America produced by Columbia University [quarterback, 1965]) CORONARY OBSTRUCTIONS AND NON-ISCHEMIC VALVE DISEASE Chairman: Robert O. Bonow, M.D. Impact of concomitant CAD on natural history when aortic and/or mitral valve diseases are present Robert O. Bonow, M.D. Threshold for additional surgery for aortic or non-ischemic mitral valve disease when CABG is the primary surgical indication Aubrey Galloway, M.D. Selection of techniques for valve surgery and CABG: impact of combined procedures involving aortic or mitral valve Lawrence Cohn, M.D. Panel Discussion/Q & A Lawrence Cohn, M.D., Chairman; Drs. Isom, Bonow, Gold/Galloway Coffee Break MITRAL VALVE DISEASE I Mark Starling, M.D. Is prophylactic beta blockade appropriate in MR? Impact of cellular pathophysiology Mark Starling, M.D. Do follow-up data now support use of tissue valves in the mitral position before age 80? Timothy Gardner, M.D. Indications for mitral valve surgery in the asymptomatic patient: do these differ in the presence vs the absence of flail leaflet? Maurice Enriquez-Sarano, M.D. Mitral valve repair for ischemic mitral insufficiency: techniques and results Delos Cosgrove, M.D. When should tricuspid valve replacement/repair accompany mitral valve surgery? Jeff Gold, M.D. Panel Discussion/Q & A Dr. Clare Hochreiter, Chairperson; Drs. Starling, Tajik, Cosgrove, Sarano, Gold, Isom, Borer RECEPTION FRIDAY, MAY 3, 2002 Continental breakfast MITRAL VALVE DISEASE II Chairman: Richard Brodman, M.D. Natural history of mitral stenosis and echocardiographic criteria and pitfalls in selecting patients for balloon valvotomy Ventricular arrhythmias in mitral regurgitation – frequency, importance, management pre and post op Clare Hochreiter, M.D. Relation of MR severity, regurgitant volume and sudden death: a “new” risk factor? Jamil Tajik, M.D. Surgical correction of AF during mitral valve replacement or repair: results of the Maze procedure James Cox, M.D. ACEI/ARB for MR: is this truly appropriate? Blase Carabello, M.D. Robotic valve surgery: how does the future look? Craig Smith, M.D. Panel Discussion/Q & A Richard Brodman, M.D., Chairman; Drs. Cox, Smith, Hahn, Hochreiter, Tajik, Carabello Coffee Break DISEASES OF THE AORTIC ROOT AND VALVE Chairman: John Elefteriadis, M.D. The bicuspid aortic valve: frequency, variations and pathological basis of associated aortic root dilatation William C. Roberts, M.D. Perspectives on diseases of the thoracic aorta John Elefteriadis, M.D. Valve repair vs replacement when of regurgitation is caused by aortic root aneurysms: relative advantages and disadvantages and impact of decision on surgical indications Leonard Girardi, M.D. Panel Discussion/Q & A Dr. Girardi, Chairman; Drs. Elefteriadis, Roberts, Isom Buffet Lunch AORTIC VALVE DISEASE I Chairman: William C. Roberts, M.D. Radiolabeled ligand imaging: future role in evaluation and prognostication? Jagat Narula, M.D., Ph.D. Criteria for valve surgery in the asymptomatic patient: current standards and effect of rate of change in objective measures? Jeffrey S. Borer, M.D. Timing of valve replacement when acute regurgitation results from endocarditis O. Wayne Isom, M.D. Results of cholesterol lowering trial for AS Valentin Fuster, M.D., Ph.D Panel Discussion/Q & A Edmund Herrold,M.D., Ph.D. Chairman; Drs. Narula, Roberts, Isom, Fuster, Borer, Stelzer Coffee Break AORTIC VALVE DISEASE II Chairman: Blase Carabello, M.D. Heart failure in aortic regurgitation: importance and cellular and molecular pathophysiology of primary fibrosis Jeffrey S. Borer, M.D. Criteria for operating on the asymptomatic patient: can we defend them? Alan Schwartz, M.D. Pitfalls in estimating prosthetic valve function from the echocardiogram Panel Discussion/Q & A Paul Stelzer, M.D. Chairman; Schwartz, Roman, Isom, Borer, Carabello Concluding remarks Drs. Isom and Borer Participants complete and submit course evaluation ADJOURN |
||||||||||||||||
Organized by: | The Howard Gilman Institute for Valvular Heart Diseases | |||||||||||||||
Invited Speakers: | Course Directors Jeffrey S. Borer, M.D/Weill Medical College of Cornell University O. Wayne Isom, M.D./Weill Medical College of Cornell University Faculty (tentative) Robert O. Bonow, M.D./Northwestern University Medical School Richard Brodman, M.D./The Albert Einstein College of Medicine Blase Carabello, M.D./Baylor College of Medicine Lawrence Cohn, M.D./Harvard Medical School James Cox, M.D./Ohio State University School of Medicine Delos Cosgrove, M.D./The Cleveland Clinic John Elefteriadis, M.D./Yale University School of Medicine Valentin Fuster, M.D., Ph.D./Mount Sinai School of Medicine Aubrey Galloway, M.D./New York University School of Medicine Timothy Gardner, M.D./University of Pennsylvania School of Medicine Leonard Girardi, M.D./Weill Medical College of Cornell University Jeffrey P. Gold, M.D./Albert Einstein College of Medicinety Edmund Herrold, M.D., Ph.D./Weill Medical College of Cornell University William Z. Hillenbrand, M.D./Columbia University College of Physicians and Surgeons Clare Hochreiter, M.D./ Weill Medical College of Cornell University Karl Krieger, M.D./Weill Medical College of Cornell University John Lamberti, M.D./Weill Medical College of Cornell University Jagat Narula, M.D., Ph.D./MCP Hahnemann University Mehmet Oz, M.D./College of Physicians and Surgeons Joseph K. Perloff, M.D./UCLA Jan Quagebeur, M.D/Columbia University College of Physicians and Surgeons William C. Roberts, M.D./Baylor University Medical Center Maurice Enrique Sarano, M.D/Mayo Medical School Allan Schwartz, M.D./ Columbia University College of Physicians and Surgeons Craig Smith, M.D./ Columbia University College of Physicians and Surgeons Mark Starling, M.D./University of Michigan Medical School Paul Stelzer, M.D./Albert Einstein College of Medicine Phyllis Supino, Ed.D./Weill Medical College of Cornell University Jamil Tajik, M.D./ Mayo Medical School |
|||||||||||||||
Deadline for Abstracts: | N/A | |||||||||||||||
Registration: | Early registration (prior to March 9, 2002) – $550 ACC members – $575 Physicians’ Assistants/Nurse Practitioners ¾ $450 (with letter from employer) Fellows & Residents - $350 (with letter from training director) All others – $650 |
|||||||||||||||
E-mail: | msljy@lesliejyerman.com | |||||||||||||||
Posted by: | leslie j. yerman | |||||||||||||||
Host: | user-2ivec3d.dialup.mindspring.com | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |